Literature DB >> 24220035

Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase.

Carolyn M Dancevic1, Fiona W Fraser, Adam D Smith, Nicole Stupka, Alister C Ward, Daniel R McCulloch.   

Abstract

The proteoglycanase clade of the ADAMTS superfamily shows preferred proteolytic activity toward the hyalectan/lectican proteoglycans as follows: aggrecan, brevican, neurocan, and versican. ADAMTS15, a member of this clade, was recently identified as a putative tumor suppressor gene in colorectal and breast cancer. However, its biosynthesis, substrate specificity, and tissue expression are poorly described. Therefore, we undertook a detailed study of this proteinase and its expression. We report propeptide processing of the ADAMTS15 zymogen by furin activity, identifying RAKR(212)↓ as a major furin cleavage site within the prodomain. ADAMTS15 was localized on the cell surface, activated extracellularly, and required propeptide processing before cleaving V1 versican at position (441)E↓A(442). In the mouse embryo, Adamts15 was expressed in the developing heart at E10.5 and E11.5 days post-coitum and in the musculoskeletal system from E13.5 to E15.5 days post-coitum, where it was co-localized with hyaluronan. Adamts15 was also highly expressed in several structures within the adult mouse colon. Our findings show overlapping sites of Adamts15 expression with other members of ADAMTS proteoglycanases during embryonic development, suggesting possible cooperative roles during embryogenesis, consistent with other ADAMTS proteoglycanase combinatorial knock-out mouse models. Collectively, these data suggest a role for ADAMTS15 in a wide range of biological processes that are potentially mediated through the processing of versican.

Entities:  

Keywords:  Development; Embryo; Extracellular Matrix; Extracellular Matrix Proteins; Metalloprotease; Proteoglycan; Skeletal Muscle

Mesh:

Substances:

Year:  2013        PMID: 24220035      PMCID: PMC3873579          DOI: 10.1074/jbc.M112.418624

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors.

Authors:  Juan Carlos Rodríguez-Manzaneque; Jennifer Westling; Shelley N-M Thai; Alfonso Luque; Vera Knauper; Gillian Murphy; John D Sandy; M Luisa Iruela-Arispe
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

Review 3.  Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 null mutant mice develop renal lesions mimicking obstructive nephropathy.

Authors:  Hitoshi Yokoyama; Takashi Wada; Ken-ichi Kobayashi; Kouji Kuno; Hiroki Kurihara; Takayuki Shindo; Kouji Matsushima
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

5.  Expression of ADAMTS1 during murine development.

Authors:  Shelley N-M Thai; M Luisa Iruela-Arispe
Journal:  Mech Dev       Date:  2002-07       Impact factor: 1.882

6.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

7.  ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.

Authors:  Gui Gao; Anna Plaas; Vivian P Thompson; Sue Jin; Fengrong Zuo; John D Sandy
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

8.  Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network.

Authors:  Ping Wang; Micky Tortorella; Kristen England; Anne-Marie Malfait; Gary Thomas; Elizabeth C Arner; Duanqing Pei
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

9.  Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation.

Authors:  Darryl L Russell; Kari M H Doyle; Scott A Ochsner; John D Sandy; JoAnne S Richards
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

10.  Expression profiling of metalloproteinases and their inhibitors in cartilage.

Authors:  Lara Kevorkian; David A Young; Clare Darrah; Simon T Donell; Lee Shepstone; Sarah Porter; Sarah M V Brockbank; Dylan R Edwards; Andrew E Parker; Ian M Clark
Journal:  Arthritis Rheum       Date:  2004-01
View more
  29 in total

1.  ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.

Authors:  Cenqi Guo; Anastasia Tsigkou; Meng Huee Lee
Journal:  Biomed Rep       Date:  2015-10-30

2.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

3.  Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5.

Authors:  Simon J Foulcer; Courtney M Nelson; Maritza V Quintero; Balagurunathan Kuberan; Jonathan Larkin; Maria T Dours-Zimmermann; Dieter R Zimmermann; Suneel S Apte
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

4.  Cell-specific and developmental expression of lectican-cleaving proteases in mouse hippocampus and neocortex.

Authors:  C Levy; J M Brooks; J Chen; J Su; M A Fox
Journal:  J Comp Neurol       Date:  2014-11-21       Impact factor: 3.215

Review 5.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

6.  Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.

Authors:  Ndeye-Aicha Gueye; Timothy J Mead; Christopher D Koch; Charles V Biscotti; Tommaso Falcone; Suneel S Apte
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 7.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

8.  Fat depot-specific gene signature and ECM remodeling of Sca1(high) adipose-derived stem cells.

Authors:  Masakuni Tokunaga; Mayumi Inoue; Yibin Jiang; Richard H Barnes; David A Buchner; Tae-Hwa Chun
Journal:  Matrix Biol       Date:  2014-04-13       Impact factor: 11.583

Review 9.  ADAMTS-5: A difficult teenager turning 20.

Authors:  Salvatore Santamaria
Journal:  Int J Exp Pathol       Date:  2020-03-27       Impact factor: 1.925

Review 10.  The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.

Authors:  Brandon Satz-Jacobowitz; Dirk Hubmacher
Journal:  Dev Dyn       Date:  2020-09-17       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.